Gilead’s initial results show remdesivir helps improve symptoms in COVID-19 patients Posted on April 29, 2020 at 1:02 pm. Gilead Sciences, Inc released initial results today from its study in which some COVID-19 patients were treated for five days [Read More]To access this content, you must be a member. Visit the Plans page for details.
